nasopharyngeal carcinoma
Conditions
Interventions
Control group:Compound Borax gargle
Sponsors
Sichuan Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. written informed consent; 2. male or female patient 18-70 years of age; 3. initial histologically or cytologically confirmed nasopharyngeal carcinoma with no metastasis; 4. patients with Stage I/II/III/IV were all included (AJCC 2010); 5. scheduled to receive radiotherapy and/or chemotherapy; 6. KPS>=70; 7. Lifetime at least >=6 months.
Exclusion criteria
Exclusion criteria: 1. patients with active oral infectious diseases, including oropharyngeal candidiasis,facialherpes or other oral diseases; 2. elderly patients with dry stomatitis; 3. patients with recurrent or residual nasopharyngeal carcinoma; 4. patients who are scheduled to receive 5-fluorouracil regimen in neoadjuvant chemotherapy or chemoradiotherapy; 5. patients with treatment of molecular targeted therapeutic drugs simultaneously; 6. patients with severe heart, liver, kidney, hematopoietic system and nervous system disease, psychotics, and patients with plasma glucose poorly controlled undertaking; 7. allergies, known or suspected anaphylaxis for drug; 8. pregnancy and/or nursing mothers,and/or female patients of childbearing potential who can not taking effective contraception in study; 9. used to participat in other clinical trials within three months; 10. alcohol and/or drug abusers; 11. patients who are considered that not suitable for study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| oral mucositis; | — |
Secondary
| Measure | Time frame |
|---|---|
| gastrointestinal mucositis;mouth pain; | — |
Countries
China
Contacts
Public ContactJinyi Lang
Outcome results
None listed